Concomitant Interstitial Lung Disease with Psoriasis

por Ishikawa, Genta, Dua, Sakshi, Mathur, Aditi, Acquah, Samuel O., Salvatore, Mary, Beasley, Mary B., Padilla, Maria L.
Publicado 2019

An Open-Label, Phase II Study of the Safety of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis (PIPF-002)

por Gotfried, Mark H., Girod, Carlos E., Antin-Ozerkis, Danielle, Burgess, Tracy, Strombom, Indiana, Stauffer, John L., Kirchgaessler, Klaus-Uwe, Padilla, Maria L.
Publicado 2018

Acute exacerbations of progressive-fibrosing interstitial lung diseases

por Kolb, Martin, Bondue, Benjamin, Pesci, Alberto, Miyazaki, Yasunari, Song, Jin Woo, Bhatt, Nitin Y., Huggins, John T., Oldham, Justin M., Padilla, Maria L., Roman, Jesse, Shapera, Shane
Publicado 2018

Pirfenidone safety and adverse event management in idiopathic pulmonary fibrosis

por Lancaster, Lisa H., de Andrade, Joao A., Zibrak, Joseph D., Padilla, Maria L., Albera, Carlo, Nathan, Steven D., Wijsenbeek, Marlies S., Stauffer, John L., Kirchgaessler, Klaus-Uwe, Costabel, Ulrich
Publicado 2017

Expert consensus on the management of adverse events and prescribing practices associated with the treatment of patients taking pirfenidone for idiopathic pulmonary fibrosis: a Del...

por Rahaghi, Franck F., Safdar, Zeenat, Brown, Anne Whitney, de Andrade, Joao A., Flaherty, Kevin R., Kaner, Robert J., King, Christopher S., Padilla, Maria L., Noth, Imre, Scholand, Mary Beth, Shifren, Adrian, Nathan, Steven D.
Publicado 2020